Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Caregivers | 15 | 2024 | 2308 | 1.910 |
Why?
|
Medication Adherence | 12 | 2024 | 2192 | 1.660 |
Why?
|
Breast Neoplasms | 27 | 2024 | 21188 | 1.570 |
Why?
|
Adaptation, Psychological | 16 | 2024 | 2666 | 1.450 |
Why?
|
Anxiety | 21 | 2024 | 4672 | 1.290 |
Why?
|
Self Efficacy | 4 | 2024 | 643 | 1.290 |
Why?
|
Quality of Life | 31 | 2024 | 13510 | 1.280 |
Why?
|
Depression | 25 | 2024 | 8231 | 1.180 |
Why?
|
Antineoplastic Agents, Hormonal | 5 | 2024 | 1535 | 0.990 |
Why?
|
Stress, Psychological | 14 | 2022 | 4530 | 0.950 |
Why?
|
Chemotherapy, Adjuvant | 8 | 2024 | 3554 | 0.920 |
Why?
|
Gastrointestinal Neoplasms | 7 | 2018 | 957 | 0.820 |
Why?
|
Affect | 7 | 2024 | 1500 | 0.790 |
Why?
|
Telemedicine | 4 | 2024 | 3110 | 0.710 |
Why?
|
Hematopoietic Stem Cell Transplantation | 5 | 2022 | 5716 | 0.530 |
Why?
|
Palliative Care | 8 | 2019 | 3644 | 0.470 |
Why?
|
Neoplasms | 13 | 2023 | 22389 | 0.440 |
Why?
|
Family | 3 | 2017 | 3208 | 0.390 |
Why?
|
Interpersonal Relations | 3 | 2017 | 1437 | 0.370 |
Why?
|
Social Support | 4 | 2017 | 2193 | 0.350 |
Why?
|
Glioma | 2 | 2022 | 3532 | 0.350 |
Why?
|
Fatigue | 4 | 2020 | 1557 | 0.340 |
Why?
|
Lung Neoplasms | 7 | 2017 | 13594 | 0.330 |
Why?
|
Middle Aged | 45 | 2024 | 223737 | 0.310 |
Why?
|
Female | 52 | 2024 | 397515 | 0.280 |
Why?
|
Brain Neoplasms | 3 | 2024 | 9213 | 0.280 |
Why?
|
Graft vs Host Disease | 1 | 2019 | 3048 | 0.270 |
Why?
|
Aged | 32 | 2024 | 171786 | 0.250 |
Why?
|
Humans | 62 | 2024 | 768970 | 0.250 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2019 | 5434 | 0.240 |
Why?
|
Patient Satisfaction | 1 | 2017 | 3492 | 0.230 |
Why?
|
Administration, Oral | 4 | 2020 | 4040 | 0.220 |
Why?
|
Combined Modality Therapy | 4 | 2022 | 8559 | 0.200 |
Why?
|
Adult | 29 | 2024 | 223851 | 0.200 |
Why?
|
Inflammation | 3 | 2017 | 10868 | 0.200 |
Why?
|
Leukocytes | 3 | 2017 | 2034 | 0.180 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2023 | 10400 | 0.180 |
Why?
|
Mastectomy | 3 | 2022 | 1850 | 0.180 |
Why?
|
Trauma, Nervous System | 1 | 2017 | 35 | 0.150 |
Why?
|
Florida | 2 | 2017 | 430 | 0.140 |
Why?
|
Arm | 1 | 2020 | 590 | 0.140 |
Why?
|
Psychotherapy | 2 | 2018 | 1654 | 0.140 |
Why?
|
Aged, 80 and over | 9 | 2020 | 59739 | 0.140 |
Why?
|
Adjuvants, Immunologic | 1 | 2022 | 999 | 0.140 |
Why?
|
Drug Therapy | 1 | 2020 | 504 | 0.140 |
Why?
|
Reminder Systems | 1 | 2020 | 388 | 0.140 |
Why?
|
Postoperative Period | 2 | 2016 | 1830 | 0.130 |
Why?
|
Phytotherapy | 1 | 2008 | 298 | 0.130 |
Why?
|
Male | 28 | 2024 | 365203 | 0.130 |
Why?
|
Cancer Care Facilities | 2 | 2018 | 428 | 0.130 |
Why?
|
Nursing Staff, Hospital | 1 | 2019 | 350 | 0.130 |
Why?
|
Patients | 1 | 2022 | 908 | 0.130 |
Why?
|
Actigraphy | 1 | 2019 | 527 | 0.130 |
Why?
|
Pilot Projects | 2 | 2020 | 8748 | 0.120 |
Why?
|
Transcription, Genetic | 2 | 2016 | 7609 | 0.120 |
Why?
|
Self Report | 4 | 2024 | 3773 | 0.120 |
Why?
|
Physical Fitness | 1 | 2019 | 744 | 0.120 |
Why?
|
Neoplasm Staging | 7 | 2019 | 11262 | 0.120 |
Why?
|
Survivors | 3 | 2019 | 2383 | 0.120 |
Why?
|
Friends | 1 | 2015 | 148 | 0.110 |
Why?
|
Psychotherapy, Brief | 1 | 2015 | 118 | 0.110 |
Why?
|
Lymphedema | 1 | 2020 | 526 | 0.110 |
Why?
|
Family Health | 2 | 2016 | 1255 | 0.110 |
Why?
|
Relaxation Therapy | 1 | 2015 | 181 | 0.110 |
Why?
|
Motor Activity | 1 | 2013 | 2713 | 0.110 |
Why?
|
Spouses | 1 | 2015 | 286 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2024 | 9442 | 0.100 |
Why?
|
Feasibility Studies | 2 | 2021 | 5323 | 0.100 |
Why?
|
Mammaplasty | 1 | 2022 | 1263 | 0.100 |
Why?
|
Young Adult | 9 | 2020 | 60131 | 0.100 |
Why?
|
Health Care Surveys | 1 | 2019 | 2437 | 0.100 |
Why?
|
Resilience, Psychological | 2 | 2016 | 807 | 0.090 |
Why?
|
Antineoplastic Agents | 3 | 2020 | 13698 | 0.090 |
Why?
|
Patient Selection | 1 | 2023 | 4265 | 0.090 |
Why?
|
Single-Blind Method | 3 | 2015 | 1586 | 0.090 |
Why?
|
Intracranial Hemorrhages | 1 | 2016 | 811 | 0.090 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2020 | 1106 | 0.090 |
Why?
|
Patient Compliance | 1 | 2021 | 2701 | 0.090 |
Why?
|
Follow-Up Studies | 7 | 2019 | 39394 | 0.090 |
Why?
|
Exercise Therapy | 1 | 2017 | 939 | 0.090 |
Why?
|
Interleukin-1beta | 1 | 2016 | 1026 | 0.080 |
Why?
|
Regression Analysis | 2 | 2018 | 6346 | 0.080 |
Why?
|
Patient-Centered Care | 1 | 2019 | 1447 | 0.080 |
Why?
|
Patient Participation | 1 | 2017 | 1448 | 0.080 |
Why?
|
Inflammation Mediators | 1 | 2017 | 1890 | 0.080 |
Why?
|
Boston | 1 | 2021 | 9377 | 0.070 |
Why?
|
Massachusetts | 1 | 2021 | 8894 | 0.070 |
Why?
|
Socioeconomic Factors | 2 | 2019 | 7861 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2018 | 2241 | 0.070 |
Why?
|
Pain | 1 | 2022 | 5100 | 0.070 |
Why?
|
Research Design | 1 | 2023 | 6214 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11886 | 0.070 |
Why?
|
Health Behavior | 1 | 2018 | 2649 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2019 | 4056 | 0.060 |
Why?
|
Postoperative Complications | 2 | 2020 | 15889 | 0.060 |
Why?
|
Interleukin-6 | 1 | 2016 | 3232 | 0.060 |
Why?
|
Stroke | 2 | 2019 | 9756 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2011 | 8664 | 0.060 |
Why?
|
Treatment Outcome | 6 | 2020 | 65480 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3235 | 0.060 |
Why?
|
Insurance, Health | 1 | 2017 | 2518 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2016 | 4356 | 0.060 |
Why?
|
Health Expenditures | 1 | 2017 | 2396 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20245 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15951 | 0.060 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2019 | 4640 | 0.060 |
Why?
|
Critical Illness | 1 | 2016 | 2754 | 0.050 |
Why?
|
Pandemics | 1 | 2023 | 8749 | 0.050 |
Why?
|
Genotype | 1 | 2017 | 13048 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2019 | 4879 | 0.050 |
Why?
|
Qualitative Research | 2 | 2024 | 3143 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7460 | 0.040 |
Why?
|
Exercise | 1 | 2017 | 5954 | 0.040 |
Why?
|
Cross-Sectional Studies | 5 | 2021 | 26395 | 0.040 |
Why?
|
Intensive Care Units | 3 | 2019 | 3800 | 0.040 |
Why?
|
Risk Factors | 4 | 2020 | 74976 | 0.040 |
Why?
|
Santalaceae | 1 | 2008 | 1 | 0.040 |
Why?
|
Mental Disorders | 1 | 2019 | 6876 | 0.040 |
Why?
|
Tumor Escape | 1 | 2011 | 372 | 0.040 |
Why?
|
Agaricales | 1 | 2008 | 31 | 0.040 |
Why?
|
Schizophrenia | 1 | 2017 | 6987 | 0.040 |
Why?
|
Emotions | 2 | 2023 | 2768 | 0.040 |
Why?
|
Epidemiologic Studies | 1 | 2020 | 677 | 0.040 |
Why?
|
Disease Management | 2 | 2020 | 2537 | 0.040 |
Why?
|
Body Image | 1 | 2022 | 646 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2024 | 2744 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2016 | 6856 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2011 | 1445 | 0.030 |
Why?
|
Fear | 1 | 2024 | 1493 | 0.030 |
Why?
|
Immunity | 1 | 2011 | 1003 | 0.030 |
Why?
|
Organ Size | 1 | 2020 | 2268 | 0.030 |
Why?
|
United States | 2 | 2021 | 73186 | 0.030 |
Why?
|
Cyclooxygenase 2 | 1 | 2017 | 597 | 0.030 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2017 | 633 | 0.030 |
Why?
|
Anger | 1 | 2016 | 405 | 0.030 |
Why?
|
Prognosis | 3 | 2020 | 30046 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2016 | 794 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2017 | 9549 | 0.030 |
Why?
|
Self Care | 1 | 2019 | 801 | 0.030 |
Why?
|
Suicidal Ideation | 1 | 2023 | 1462 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2360 | 0.030 |
Why?
|
Chemokines | 1 | 2017 | 963 | 0.030 |
Why?
|
Focus Groups | 1 | 2019 | 1462 | 0.030 |
Why?
|
Prospective Studies | 3 | 2022 | 54962 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2017 | 904 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2019 | 1515 | 0.020 |
Why?
|
Neurosciences | 1 | 2016 | 385 | 0.020 |
Why?
|
Health Surveys | 1 | 2020 | 4055 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2019 | 81903 | 0.020 |
Why?
|
Time Factors | 2 | 2017 | 40261 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2017 | 3810 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2019 | 2339 | 0.020 |
Why?
|
Odds Ratio | 1 | 2019 | 9684 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2017 | 6030 | 0.020 |
Why?
|
Psychometrics | 1 | 2016 | 3066 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5891 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2017 | 4926 | 0.020 |
Why?
|
Cause of Death | 1 | 2015 | 3721 | 0.010 |
Why?
|
Health Status | 1 | 2017 | 4095 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 2017 | 3081 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13674 | 0.010 |
Why?
|
Mental Health | 1 | 2016 | 3275 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2011 | 12801 | 0.010 |
Why?
|
Cytokines | 1 | 2017 | 7453 | 0.010 |
Why?
|
Child | 2 | 2021 | 80960 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2017 | 3421 | 0.010 |
Why?
|
Comorbidity | 1 | 2016 | 10592 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12562 | 0.010 |
Why?
|
Adolescent | 2 | 2019 | 89244 | 0.010 |
Why?
|
Cognition | 1 | 2015 | 7081 | 0.010 |
Why?
|
Body Mass Index | 1 | 2016 | 13055 | 0.010 |
Why?
|
Animals | 1 | 2008 | 169335 | 0.000 |
Why?
|
Concepts
(172)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(56)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_